Anticancer Prodrugs for Application in Monotherapy Targeting Hypoxia, Tumor-Associated Enzymes, and Receptors

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|8|9|1093-1122

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.8, Iss.9, 2001-07, pp. : 1093-1122

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Tumor-Associated Antigens to the MHC Class I Presentation Pathway

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 7, Iss. 2, 2007-06 ,pp. : 99-109

Bentham Science Publishers

Access to resources Recommend Favorite

Imaging Agents in Targeting Tumor Hypoxia

By  

Current Medicinal Chemistry, Vol. 23, Iss. 17, 2016-05 ,pp. : 1775-1800

Bentham Science Publishers

Access to resources Recommend Favorite

Radiolabelled Probes Targeting Tumor Hypoxia for Personalized Medicine

By  

Current Pharmaceutical Design, Vol. 20, Iss. 14, 2014-04 ,pp. : 2308-2318

Bentham Science Publishers

Access to resources Recommend Favorite

Small Molecule Toxins Targeting Tumor Receptors

By  

Current Pharmaceutical Design, Vol. 10, Iss. 19, 2004-07 ,pp. : 2311-2334

Bentham Science Publishers

Access to resources Recommend Favorite

The Japanese experiences with hypoxia-targeting pharmacoradiotherapy: from hypoxic cell sensitisers to radiation-activated prodrugs

By Shibamoto Yuta   Sugie Chikao   Ito Masato   Ogino Hiroyuki  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 12, 2004-12 ,pp. : 2459-2467

Informa Healthcare

Access to resources Recommend Favorite